Industry-leading infrastructure for collecting and analyzing patient outcomes data for commercialized cell and gene therapies.
Outcomes Data Collection and Analysis
Industry-leading infrastructure for collecting and analyzing patient outcomes data for commercialized cell and gene therapies.
Extensive data infrastructure for collection and analysis
Developing protocols and secure data storage systems for collecting, maintaining, and analyzing outcomes data for patients post-therapeutic intervention is both time-consuming and costly, with no room for error.
Through our research partner, the CIBMTR® (Center for International Blood and Marrow Transplant Research®), we collaborate with the global scientific community to advance cellular therapy worldwide to increase survival and enrich quality of life for patients.
Our outcomes registry facilitates critical observational and interventional research through scientific and statistical expertise, a large network of centers, an extensive clinical outcomes database and a unique biospecimen repository.
CIBMTR research activity
0
patient outcomes
0
+
publications
0
+
active clinical studies
0
transplant centers participating in research
An experienced research and outcomes partner
Our team of scientists and biostatisticians has deep knowledge and experience collecting and managing critical outcomes data. Their capabilities include:
Collaborating with partners to determine reporting and analysis timelines required by regulatory authorities
Providing customized data collection, secure data storage and custom data extracts
Supplying standard reports and analytics, with the option to build customized reports as needed
Offering scientific and statistical consulting for research design and data analytics
Performing statistical analysis and interpretation
Get the conversation started
We can help to plan for—and execute— long-term data collection and analysis for allogeneic or autologous cell or gene therapies moving towards commercialization.